Newsletter No. 68 -- November 2003
CIP Web Site: http://cip.cancer.gov/CANCER IMAGING PROGRAM is our new name.
RSNA - RADIOLOGIC SOCIETY OF NORTH AMERICA
89th Scientific Assembly and Annual Meeting, Nov. 30 - Dec. 5, 2003, McCormick Place,
5TH NATIONAL FORUM ON BIOMEDICAL IMAGING IN ONCOLOGY
January 29-30, 2004, Hyatt Regency Bethesda, Bethesda, MD
SPIE INTERNATIONAL SYMPOSIUM: MEDICAL IMAGING 2004
14 - 19 February 2004, Town & Country Hotel, San Diego, CA
2004 BIOMEDICAL IMAGING RESEARCH OPPORTUNITIES WORKSHOP (BIROW II) February 25-26, 2004, Bethesda Marriott Hotel, Bethesda, MD. This workshop is the second in a series of five being organized by the AAPM, RSNA, BMES, ARR and AIMBE.
SOCIETY OF INTERVENTIONAL RADIOLOGY 29th Annual Scientific Meeting
Phoenix Civic Plaza, Phoenix, Arizona, March 25 - 30, 2004
ACADEMY OF MOLECULAR IMAGING ANNUAL MEETING
The Academy of Molecular Imaging announces that it is now accepting abstract submissions for the 2004 AMI Annual Conference, to be held March 28-31, 2004, at the Gaylord Palms Resort and Convention Center in Orlando, Florida.
SOCIETY OF NUCLEAR MEDICINE 51st ANNUAL MEETING
June 19-23, 2004, Pennsylvania Convention Center, Philadelphia, PA.
BECON/BISTIC SYMPOSIUM: Informatics for Clinical Decision-making in the 21st Century
June 21-22, 2004, Natcher Auditorium, NIH Campus, Bethesda, MD
CARS 2004 Computer Assisted Radiology and Surgery
June 23-26, 2004, Hilton & Towers Hotel, Chicago, IL, USA
SEVENTEENTH IEEE SYMPOSIUM ON COMPUTER BASED MEDICAL SYSTEMS (CBMS 2004) June 24-25, 2004, Hotel Four Points by Sheraton, Bethesda, Maryland
The Cancer Imaging Program of the NCI requests submissions for its Development of Clinical Imaging Drugs and Enhancers (DCIDE) initiative. The goal is the rapid movement of promising, novel cancer imaging enhancers or molecular probes from the laboratory to proof of principle clinical trials. See the web site for details.
The latest release of the NIH Commons web site allows all NIH grantee organizations to interact with grants data, to check the status of grant applications, including viewing scores and summary statements when they are ready, and to submit progress reports on line, among a number of functions. Both applicants and grants administrators should become familiar with the Commons.
1. NIH ROADMAP
The NIH Roadmap is an integrated vision to deepen our understanding of biology, stimulate interdisciplinary research teams, and reshape clinical research to accelerate medical discovery and improve people's health. Most of the initiatives will begin in FY 2004. Other initiatives will start in FY 2005 and beyond, depending upon the budget and other emerging needs. The three NIH Roadmap themes are as follows: new pathways to discovery, research teams of the future, and re-engineering the clinical research Enterprise.
2. REVISED RFA DESIGNATORS FOR NIH ROADMAP INITIATIVES (NIH)(NOT-OD-04-008)
In order to underscore the trans-NIH nature and increase the visibility of initiatives issued under the Director's Roadmap (see http://nihroadmap.nih.gov/), the RFA number of the following announcements will be changed to incorporate the Roadmap designator (RM). All future Requests for Applications (RFAs) issued under the NIH Roadmap will include this designator. NOTE TO ALL APPLICANTS: All applications responding to Roadmap RFAs must cite the new Roadmap RFA number in Item 2 on the face page of their applications (see http://grants.nih.gov/grants/funding/phs398/fp1.pdf ). Applications that have already been received in response to first RFA listed below (Development of High Resolution Probes for Cellular Imaging) will be recoded by the NIH. Here is one example; look at the notice for the rest.
DEVELOPMENT OF HIGH RESOLUTION PROBES FOR CELLULAR IMAGING -
Old RFA Number: RFA-GM-03-013, New RFA Number: RFA-RM-04-001
3. SMALL ANIMAL IMAGING RESOURCE PROGRAMS(NCI)(CA-04-011)
LETTER OF INTENT RECEIPT DATE: November 18, 2003
APPLICATION RECEIPT DATE: December 18, 2003
The National Cancer Institute (NCI) invites applications from extramural investigators for Small Animal Imaging Resource Programs (SAIRPs). These grants will support (a) shared imaging research resources to be used by cancer investigators, (b) research related to small animal imaging technology, and (c) training of both professional and technical support personnel interested in the science and techniques of small animal imaging.
4. NOVEL TECHNOLOGIES FOR NONINVASIVE DETECTION, DIAGNOSIS AND TREATMENT OF CANCER (NCI)(NOT-CA-03-039)
The Unconventional Innovations Program (UIP) of the National Cancer Institute (NCI) is seeking revolutionary technologies for cancer research. The UIP is soliciting proposals for the development of multifunctional technology platforms to support minimally intrusive approaches that integrate: a) sensing of the fundamental signatures of precancers, or early, metastatic or recurring cancers in the living body; b) transmission of signature information to an external monitor; c) controlled, specific, treatment; d) monitoring of the effects of treatment. The detailed Broad Agency Announcement is available on the web site of the Research Contracts Branch, NCI at: http://rcb.cancer.gov/rcb-internet/appl/rfp/published_rfps.jsp with instructions for submission of proposal and evaluation criteria. Investigators are encouraged to visit the UIP websites; http://otir.cancer.gov/tech/uip.html for a program overview, and http://otir.cancer.gov/tech/uip_awards.html for abstracts of currently funded UPI contractors.
5. BIOENGINEERING RESEARCH PARTNERSHIPS (BRP) (NIH)(PAR-04-023)
LETTER OF INTENT RECEIPT DATES: November 21, 2003; June 20, 2004; November
20, 2004; June 19, 2005; November 20, 2005; and June 22, 2006
APPLICATION RECEIPT DATES: January 21, 2004; August 20, 2004; January 20,
2005; August 19, 2005; January 20, 2006; and August 22, 2006
Participating Institutes and Centers (ICs) of the National Institutes of Health (NIH) invite applications for R01 awards to support Bioengineering Research Partnerships (BRPs) for basic, applied, and translational multi-disciplinary research that addresses important biological or medical research problems. In the context of this program, a partnership is a multi-disciplinary research team that applies an integrative, systems approach to develop knowledge and/or methods to prevent, detect, diagnose, or treat disease or to understand health and behavior.
6. CURRICULUM DEVELOPMENT AWARD IN INTERDISCIPLINARY RESEARCH (NIH)(RFA-RM-04-007)
THIS RFA IS DEVELOPED AS AN NIH ROADMAP INITIATIVE (http://nihroadmap.nih.gov/). ALL NIH INSTITUTES AND CENTERS PARTICIPATE IN ROADMAP INITIATIVES. THE RFA WILL BE ADMINISTERED BY THE NIGMS ON BEHALF OF THE NIH.
LETTER OF INTENT RECEIPT DATE: January 27, 2004
APPLICATION RECEIPT DATE: February 24, 2004
The Curriculum Development Award in Interdisciplinary Research supports the development of innovative courses, curricula and educational approaches designed to train interdisciplinary scientists in emerging areas of biomedical, behavioral and quantitative sciences. These programs are focused on preparing undergraduate, predoctoral, or postdoctoral candidates, or combinations of these, to conduct research in team settings that are highly interdisciplinary and collaborative and to train future leaders who can catalyze the integration of multiple disciplines.
7. SHORT PROGRAMS FOR INTERDISCIPLINARY RESEARCH TRAINING (NIH) (RFA-RM-04-008)
LETTER OF INTENT RECEIPT DATE: January 14, 2004; January 14, 2005
APPLICATION RECEIPT DATE: February 11, 2004; February 11, 2005
The purpose of this NIH Roadmap Initiative RFA is to promote training in multiple disciplines so that this type of creative problem solving and fusion of disciplines into novel "interdisciplines" is more likely to occur. This RFA will use the NIH R13 award mechanism. The anticipated award dates are September 30, 2004 and September 30, 2005.
8. QUANTUM PROJECTS: TECHNOLOGY-BASED ADVANCES IN HEALTHCARE (NIBIB)
RESPONSE DUE DATE: January 9, 2004
The National Institute of Biomedical Imaging and Bioengineering (NIBIB) solicits suggestions for major problems that need to be solved or research advances that represent high-impact, large-scale, technology-based projects and will result in significant (quantum) improvements in disease treatment or quality of life. The NIBIB seeks your help in identifying major problems or research advances that require collaborative, multi-disciplinary efforts; will result in a product or benefit that provides a significant improvement in healthcare; are based on technological approaches and applications; and can be accomplished in a five-to-ten year time period. Respondents are asked to submit a one-page (maximum) summary.
9. MENTORED CAREER DEVELOPMENT AWARDS: CHANGE IN NIH POLICY CONCERNING CONCURRENT SUPPORT FROM CAREER DEVELOPMENT AWARD AND A RESEARCH GRANT (NIH) (NOT-OD-04-007)
With this notice, the National Institutes of Health (NIH) modifies its policy on mentored career development awards (K Awards) to allow award recipients to hold concurrent support from their career award and a competing research grant when recognized as a Principal Investigator or
subproject Director. Thus mentored career award recipients in the last two years of their support period will be permitted to reduce the level of effort required for the career award and replace that effort with an NIH research grant or subproject provided they remain in a mentored situation.
10. AMERICAN CHEMICAL SOCIETY SUMMER SCHOOLS IN NUCLEAR AND RADIOCHEMISTRY
Application Deadline: February 1, 2004
The ACS Summer Schools in Nuclear and Radiochemistry are funded by the U.S. Department of Energy to offer undergraduates an opportunity to complete coursework on this topic through ACS accredited chemistry degree programs at San Jose State University or the State University of New York at Stony Brook. Qualified students should be undergraduates entering their junior or senior year in the Fall 2004.
The Cancer Imaging Program at NCI has created this e-mail distribution list to notify interested people about funding opportunities and other issues related to imaging research. Its primary purpose is to call your attention to important, relevant information on NIH Web pages, or in the NIH Guide. Occasionally it may be used to clarify areas of confusion, or disseminate answers to frequently asked questions.
If you wish to remain on the list, no action is necessary. If you wish to be added to the list (or removed from it), please contact Ms. Johnnie Smith by return e-mail (firstname.lastname@example.org).
Cancer Imaging Program
Division of Cancer Treatment and Diagnosis, NCI
EPN, Room 6000 - MSC-7412
6130 Executive Boulevard
Bethesda, MD 20892-7412
Tel: 301 496 9531
Fax: 301 480 3507